Pharmaron Beijing : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
February 24, 2022 at 06:32 am EST
Share
[title]
[date]
[link]
[market]
[doc type]
[stock code]
[stock name]
PROFIT WARNING
24/02/2022 19:26
Link
SEHK
pdf
01930
SHINELONG
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:26
Link
SEHK
htm
03759
PHARMARON
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:24
Link
SEHK
htm
01858
CHUNLI MEDICAL
Date of Board Meeting
24/02/2022 19:24
Link
SEHK
pdf
03613
TONGRENTANGCM
ANNOUNCEMENT OF THE 2021 FOURTH QUARTER AND FULL YEAR UNAUDITED FINANCIAL RESULTS AND ANNUAL DIVIDEND
24/02/2022 19:23
Link
SEHK
pdf
02518
AUTOHOME-S
INTERIM RESULTS ANNOUNCEMENT 2021/2022
24/02/2022 19:23
Link
SEHK
pdf
00825
NWDS CHINA
POSITIVE PROFIT ALERT
24/02/2022 19:22
Link
SEHK
pdf
02528
FW FASHION INT
ANNOUNCEMENT PROPOSED CHANGE OF ACCOUNTING FIRMS
24/02/2022 19:22
Link
SEHK
pdf
03618
CQRC BANK
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:21
Link
SEHK
htm
01858
CHUNLI MEDICAL
INSIDE INFORMATION UNAUDITED FINANCIAL RESULTS FOR THE FOURTH QUARTER AND THE YEAR ENDED 31 DECEMBER 2021 ANNOUNCED BY OUR CONTROLLING SHAREHOLDER, NETEASE, INC.
24/02/2022 19:21
Link
SEHK
pdf
09899
CLOUD VILLAGE
ANNOUNCEMENT NOMINATION OF NON-EXECUTIVE DIRECTOR
24/02/2022 19:18
Link
SEHK
pdf
03618
CQRC BANK
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:18
Link
SEHK
htm
00390
CHINA RAILWAY
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:16
Link
SEHK
htm
01858
CHUNLI MEDICAL
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:16
Link
SEHK
htm
03618
CQRC BANK
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:14
Link
SEHK
htm
01858
CHUNLI MEDICAL
RESULTS OF THE FIRST GRANT OF THE 2021 RESTRICTED SHARE INCENTIVE SCHEME
24/02/2022 19:14
Link
SEHK
pdf
00390
CHINA RAILWAY
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2021
24/02/2022 19:12
Link
SEHK
pdf
01960
TBKS HLDGS
POSITIVE PROFIT ALERT
24/02/2022 19:12
Link
SEHK
pdf
01785
CHENGDU EXPWAY
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
24/02/2022 19:10
Link
SEHK
htm
06837
HAITONG SEC
JOINT ANNOUNCEMENT UPDATE ON FULFILMENT OF CONDITION (1) PRE-CONDITIONAL PROPOSAL FOR THE PRIVATISATION OF AKM INDUSTRIAL COMPANY LIMITED BY THE JOINT OFFERORS BY WAY OF A SCHEME OF ARRANGEMENT UNDER SECTION 673 OF THE COMPANIES ORDINANCE AND (2) PROPOSED WITHDRAWAL OF LISTING OF AKM INDUSTRIAL COMPANY LIMITED
24/02/2022 19:09
Link
SEHK
pdf
01639
AKM INDUSTRIAL
Attachments
Original Link
Original Document
Permalink
Disclaimer
Pharmaron Beijing Co. Ltd. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 11:29:33 UTC.
Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows:
- laboratory services (61.3%);
- development and production of chemical processes and formulations (23.5%);
- clinical research services (12.8%);
- other (2.4%);
Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).
Pharmaron Beijing : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section